Search Results - "Kure, Elin"
-
1
Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing
Published in PloS one (17-04-2012)“…We present the results of a global study of dysregulated miRNAs in paired samples of normal mucosa and tumor from eight patients with colorectal cancer…”
Get full text
Journal Article -
2
Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
Published in Acta oncologica (02-09-2018)“…The introduction of immune check-point inhibition in non-small cell lung cancer (NSCLC) therapy represents improved prospects for the patients. The response…”
Get more information
Journal Article -
3
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
Published in British journal of cancer (01-06-2018)“…Background Mutation status of RAS and BRAF , as well as serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), are biomarkers…”
Get full text
Journal Article -
4
Clinicopathological factors associated with tumour‐specific mutation detection in plasma of patients with RAS‐mutated or BRAF‐mutated metastatic colorectal cancer
Published in International journal of cancer (15-09-2021)“…Detection of tumour‐specific circulating cell‐free DNA in plasma (ctDNA) fails in a significant number of cases depending on the clinical context. The primary…”
Get full text
Journal Article -
5
Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation
Published in PLoS computational biology (18-11-2024)“…Aberrant DNA methylation contributes to gene expression deregulation in cancer. However, these alterations’ precise regulatory role and clinical implications…”
Get full text
Journal Article -
6
Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
Published in Cancer epidemiology, biomarkers & prevention (01-02-2022)“…Patients with right-sided colon cancer (RCC) and left-sided colon cancer (LCC) differ clinically and molecularly. The main objective was to investigate…”
Get full text
Journal Article -
7
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis
Published in British journal of cancer (01-08-2022)“…Background We investigate the current knowledge on circulating tumour DNA (ctDNA) and its clinical utility in predicting outcomes in patients with metastatic…”
Get full text
Journal Article -
8
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study
Published in Acta oncologica (01-01-2016)“…Multimodality treatment (MMT) improves survival for patients with pancreatic ductal adenocarcinoma (PDAC). The surgery-first (SF) strategy is the most…”
Get more information
Journal Article -
9
High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence
Published in PloS one (20-03-2015)“…Development of colorectal cancer (CRC) may result from a dysfunctional interplay between diet, gut microbes and the immune system. The ABC transport proteins…”
Get full text
Journal Article -
10
Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
Published in International journal of cancer (15-11-2020)“…Personalised cancer treatment depends on identification of therapeutically relevant biological subgroups of patients for assessing effect of treatment and to…”
Get full text
Journal Article -
11
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
Published in British journal of cancer (09-05-2017)“…Background: The NORDIC-VII study is a randomised phase III trial of cetuximab plus continuous or intermittent fluorouracil, folinic acid, and oxaliplatin…”
Get full text
Journal Article -
12
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
Published in Journal of clinical oncology (20-05-2012)“…The NORDIC-VII multicenter phase III trial investigated the efficacy of cetuximab when added to bolus fluorouracil/folinic acid and oxaliplatin (Nordic FLOX),…”
Get full text
Journal Article -
13
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
Published in Oncotarget (15-11-2016)“…The aim was to explore the prognostic significance of IL-6 and markers of systemic inflammatory response (SIR), in particular C-reactive protein (CRP), in…”
Get full text
Journal Article -
14
Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis
Published in PloS one (28-08-2014)“…Inflammation is a major risk factor for development of colorectal cancer (CRC). Prostaglandin synthase cyclooxygenase-2 (COX-2) encoded by the PTGS2 gene is…”
Get full text
Journal Article -
15
Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
Published in BMC cancer (20-11-2012)“…Abstract Background Recent studies have reported associations between a variant allele in a let-7 microRNA complementary site (LCS6) within the 3 ′…”
Get full text
Journal Article -
16
Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines
Published in PloS one (22-08-2014)“…Pancreatic adenocarcinoma is one of the most lethal cancer types, currently lacking efficient treatment. The heterogeneous nature of these tumours are poorly…”
Get full text
Journal Article -
17
Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: Pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01-03-2019)“…The clinical relevance of the classification of ampullary adenocarcinoma (AC) into pancreatobiliary (PB) or intestinal (Int) subtypes has not been resolved…”
Get full text
Journal Article -
18
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
Published in Frontiers in oncology (29-04-2022)“…Lung cancer is a common disease with a poor prognosis. Genomic alterations involving the gene are common in lung carcinomas, although much is unknown about how…”
Get full text
Journal Article -
19
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Published in Nature cell biology (01-06-2015)“…Pancreatic ductal adenocarcinomas (PDACs) are highly metastatic with poor prognosis, mainly due to delayed detection. We hypothesized that intercellular…”
Get full text
Journal Article -
20
The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
Published in BMC cancer (10-02-2011)“…Compromised epithelial barriers are found in dysplastic tissue of the gastrointestinal tract. Claudins are transmembrane proteins important for tight…”
Get full text
Journal Article